Call for Abstracts

INSAR 2026 will be in Prague, Czech Republic

April 22 to 25, 2026

 

Abstract Submission Dates:
September 2, 2025 - October 16, 2025

Please review topic submission categories and keywords here prior to submitting.

 

The INSAR Abstract Submission window opened earlier to provide additional time for eligible researchers to request feedback through the Science Development Advisory Program (see below). Please continue checking your inbox or follow International Society for Autism Research (INSAR) on social media for announcements.


Continuing for INSAR 2026

Science Development Advisory Program

The INSAR Scientific Program Committee, in collaboration with the Global Senior Leadership and Cultural Diversity Committees, is continuing its initiative to support participation from researchers working in under-represented regions (including low- and middle-income countries) and under-resourced settings within high-income countries. The program also provides support for individuals who require English-language assistance in preparing their abstracts for the 2026 Annual Meeting in Prague.

The program offers pre-submission feedback on abstracts, focusing on clarity of writing and overall presentation before final submission.

  • Draft portal opens: September 2, 2025
  • Draft submission deadline: October 2, 2025
  • Feedback returned by: October 9, 2025
  • Final abstract deadline: October 16, 2025

To request support, upload a draft abstract to Confex, tick the box indicating that you are requesting pre-submission feedback and confirm eligibility.

Eligibility

Applicants must meet one of the following:

  1. Currently (or within the past two years) conducting research entirely within a low-resource setting (e.g., LMIC or under-resourced environment in a high-income country) without regular access to a senior mentor experienced in English-language international scientific publication.
  2. Have limited English fluency and no regular access to a research mentor experienced in English-language international scientific publication.

Researchers based at, or closely collaborating with, higher-resourced institutions are not eligible.



Expedited Initial Review Program for Abstract Acceptance/Rejection Decisions for Individuals Requiring Visa Applications for Conference Travel

To reduce barriers to attending the INSAR Annual Meeting resulting from lengthy wait-times for visa requests, we are offering an expedited initial review for selected abstract submitters who would benefit from an earlier decision for visa application purposes to attend the INSAR Annual Meeting in Prague, Czech Republic, in 2026.

This program will only provide information on whether an abstract is accepted or rejected. Information on the timing and format of presentations will not be provided during the expedited initial review. All expedited review abstracts will still subsequently undergo the full review process to determine the presentation format (oral vs poster).


Eligibility Criteria for INSAR 2026

This service is only available if the presenting author meets all of the following criteria:

A) Requires a visa to enter the Schengen Area (including Czech Republic) for conference travel.
B) Is not a citizen of a Schengen Area/EU member state or another visa-exempt country (e.g., United States, Canada, Australia, Japan, United Kingdom, Israel, etc.).
C) Does not meet any ineligibility criteria under Schengen visa regulations (e.g., prior overstays, entry bans, or other restrictions).
D) Is willing for their abstract to be accepted as a poster* in the expedited process.


How to Apply

Individuals may request this expedited initial review during abstract submission by ticking the box marked:
“I am requesting expedited initial review for visa application purposes only.”
They must then confirm eligibility by answering the required questions.


Important Notes

  • Participation in the expedited initial review program will not affect final decisions regarding the format of presentations.
  • Because final formats cannot be determined until all full reviews are completed, abstracts from authors who will only accept an oral presentation will not be evaluated during the expedited initial review.
  • Authors should apply for visas as early as possible—typically 3–4 months before travel—to account for processing times at Czech/Schengen consulates.



Mission Statement:
To promote and disseminate the highest quality autism research globally.


INSAR is a 501(c)(3) tax-exempt organization.

Contact Us